Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning.
Banerjee S, Wu Y, Bingham KS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Oliver LD, Power JD, Rothschild AJ, Sirey JA, Voineskos AN, Whyte EM, Alexopoulos GS, Flint AJ; STOP-PD II Study Group. Banerjee S, et al. Among authors: alexopoulos gs. Psychol Med. 2024 Apr;54(6):1142-1151. doi: 10.1017/S0033291723002945. Epub 2023 Oct 11. Psychol Med. 2024. PMID: 37818656
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
Song J, Mulsant BH, Sanches M, Alexopoulos GS, Marino P, Meyers BS, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ, Gerretsen P; STOP-PD II Study Group. Song J, et al. Among authors: alexopoulos gs. J Affect Disord. 2023 Mar 15;325:29-34. doi: 10.1016/j.jad.2022.12.078. Epub 2022 Dec 30. J Affect Disord. 2023. PMID: 36592671 Clinical Trial.
Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication.
Tani H, Moxon-Emre I, Forde NJ, Neufeld NH, Bingham KS, Whyte EM, Meyers BS, Alexopoulos GS, Hoptman MJ, Rothschild AJ, Uchida H, Flint AJ, Mulsant BH, Voineskos AN. Tani H, et al. Among authors: alexopoulos gs. Brain Imaging Behav. 2024 Feb;18(1):117-129. doi: 10.1007/s11682-023-00807-0. Epub 2023 Nov 2. Brain Imaging Behav. 2024. PMID: 37917311 Free PMC article. Clinical Trial.
The relationship of white matter microstructure with psychomotor disturbance and relapse in remitted psychotic depression.
Bingham KS, Calarco N, Dickie EW, Alexopoulos GS, Butters MA, Meyers BS, Marino P, Neufeld NH, Rothschild AJ, Whyte EM, Mulsant BH, Flint AJ, Voineskos AN. Bingham KS, et al. Among authors: alexopoulos gs. J Affect Disord. 2023 Aug 1;334:317-324. doi: 10.1016/j.jad.2023.04.136. Epub 2023 May 4. J Affect Disord. 2023. PMID: 37149056 Clinical Trial.
Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study.
Men X, Marshe V, Elsheikh SS, Alexopoulos GS, Marino P, Meyers BS, Mulsant BH, Rothschild AJ, Voineskos AN, Whyte EM, Kennedy JL, Flint AJ, Müller DJ. Men X, et al. Among authors: alexopoulos gs. Neuropsychobiology. 2023;82(3):168-178. doi: 10.1159/000529637. Epub 2023 Apr 4. Neuropsychobiology. 2023. PMID: 37015192 Free PMC article. Clinical Trial.
350 results